• Info
  • Insider Ownership

Insider Trading & Ownership of Eran Broshy

Location
Somerset, NJ
Summary
The estimated net worth of Eran Broshy is at least $2,421,242 dollars as of 01 Dec 2025. Eran Broshy is the Director of Theravance Biopharma, Inc. and owns shares of Theravance Biopharma, Inc. (TBPH) stock worth about $1.72M. Eran Broshy is the Director, Chairman of Certara, Inc. and owns shares of Certara, Inc. (CERT) stock worth about $697.4K.
Signature
/s/ Corinna Liebowitz, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Eran Broshy files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Eran Broshy

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TBPH Theravance Biopharma, Inc. Director $1,723,812 -$1,399,270 -45% 26 Nov 2025
CERT Certara, Inc. Director, Chairman $697,430 21 May 2025

Insider Transactions Reported by Eran Broshy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.